When you want to buy, you buy Titan Pharmaceuticals (TSXV:TPRX)

A biotech firm that has raised a record $1.6 billion in a $15.9 billion Series B round has a long way to go to make it big.However, that doesn’t mean that it’s impossible to imagine Titan Pharma, a Canadian company with no history in pharmaceuticals, becoming a dominant player in the field.Read more from Business…

Read More